Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:BCR

C.R. Bard (BCR) Stock Price, News & Analysis

C.R. Bard logo

About C.R. Bard Stock (NYSE:BCR)

Key Stats

Today's Range
$331.24
$331.24
50-Day Range
N/A
52-Week Range
$222.42
$337.73
Volume
N/A
Average Volume
679,456 shs
Market Capitalization
N/A
P/E Ratio
21.91
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

C. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs.

Receive BCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for C.R. Bard and its competitors with MarketBeat's FREE daily newsletter.

BCR Stock News Headlines

D&D: Every Bard College, Ranked
Download Our Tesla Ebook For Free
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
Bard College welcomes refugee students
DnD 5e: Every Bard College, Ranked
See More Headlines

BCR Stock Analysis - Frequently Asked Questions

C.R. Bard Inc (NYSE:BCR) released its quarterly earnings data on Wednesday, October, 25th. The medical instruments supplier reported $3.02 EPS for the quarter, beating analysts' consensus estimates of $2.96 by $0.06. C.R. Bard's quarterly revenue was up 5.1% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that C.R. Bard investors own include Becton, Dickinson and Company (BDX), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), AbbVie (ABBV), Baxter International (BAX), Boston Scientific (BSX) and Johnson & Johnson (jnj).

Company Calendar

Last Earnings
10/25/2017
Today
11/24/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
CUSIP
06738310
CIK
9892
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NYSE:BCR) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners